logo
Select company
Select metric
$ -11.3MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
24
Sector
59
Industry
28
History
90
$ 1.14Close
$ 0.39 - $ 1.32 52-Week Range
Ticker Information

Ticker

TLPH

Company Name

TALPHERA INC

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Exchange

NASDAQ

TALPHERA INC - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

TLPH - EBITDA Historical data
DateDepreciation, Amortization & AccretionEarning Before Interest & Taxes (EBIT)Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
6/30/2025$ 0$ -11.3M$ -11.3M
3/31/2025$ 0$ -11.64M$ -11.64M
12/31/2024$ 0$ -13M$ -13M
9/30/2024$ 0$ -15.66M$ -15.66M
6/30/2024$ 0$ -13.66M$ -13.66M
3/31/2024$ 49K$ -13.74M$ -13.69M
12/31/2023$ 311K$ -18.26M$ -17.95M
9/30/2023$ 653K$ -20.6M$ -19.94M
6/30/2023$ 1.08M$ -25.73M$ -24.66M
3/31/2023$ 1.49M$ 49.12M$ 50.61M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • TALPHERA INC's latest trailing twelve months (TTM) EBITDA stands at $ -40.72M.
  • Over the past 5 years, TALPHERA INC's average EBITDA has been $ -8.52M.
  • The median EBITDA for TALPHERA INC during this period was $ -16.8M
  • TALPHERA INC reached its highest EBITDA over the past 5 years at $ 50.61M.
  • The lowest EBITDA recorded by TALPHERA INC in the same timeframe $ -40.72M

TALPHERA INC's EBITDA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA Benchmarks
CompanyEBITDA
CDIO : CARDIO DIAGNOSTICS HOLDINGS INC $ -5.85MBFRG : BULLFROG AI HOLDINGS INC $ -6.93MHSCS : HEARTSCIENCES INC $ -7.98MCELZ : CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC $ -5.65MIBO : IMPACT BIOMEDICAL INC $ -36.2MSHPH : SHUTTLE PHARMACEUTICALS HOLDINGS INC $ -11.83MADTX : ADITXT INC $ -29.78MADIL : ADIAL PHARMACEUTICALS INC $ -8.45MDWTX : DOGWOOD THERAPEUTICS INC $ -24.34MRNAZ : TRANSCODE THERAPEUTICS INC $ -24.27M

Similar metrics to EBITDA:

Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
EBIT + DepAmor
(=) EBITDA EBITDA for TALPHERA INC is calculated as follows: EBIT [ $ -42.7M ] + DepAmor [ $ 1.99M ]
(=) EBITDA [ $ -40.72M ]

TLPH - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years

$ -40.72M

Minimum

Sep 30, 2020

$ 50.61M

Maximum

Mar 31, 2023

$ -8.52M

Average

$ -16.8M

Median

EBITDA Benchmark Analysis

 The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.87M with a standard deviation of $ 166.99M.
The following table provides additional summary stats:
EBITDA in the Market:
filtered constituents3.24K
min$ -493.3M
max$ 590.6M
average$ 58.87M
median$ 8.87M
std$ 166.99M